These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38664256)

  • 1. A novel classification of posterior pelvic exenteration to assess prognosis in female patients with locally advanced primary rectal cancer: a retrospective cohort study from China PelvEx collaborative.
    Li Y; Zhuang M; Hu G; Zhang J; Qiu W; Mei S; Tang J
    Int J Colorectal Dis; 2024 Apr; 39(1):59. PubMed ID: 38664256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic posterior pelvic exenteration is safe and feasible for locally advanced primary rectal cancer in female patients: a comparative study from China PelvEx collaborative.
    Zhuang M; Chen H; Li Y; Mei S; Liu J; Du B; Wang X; Wang X; Tang J
    Tech Coloproctol; 2023 Nov; 27(11):1109-1117. PubMed ID: 37243857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior pelvic exenteration for primary rectal cancer.
    Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
    Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 6. Short- and long-term outcomes of laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: a single-center propensity score matching analysis.
    Tang J; Liu J; Du B; Zhang J; Zheng L; Wang X; Wan Y
    Tech Coloproctol; 2023 Jan; 27(1):43-52. PubMed ID: 36194310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
    Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
    Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    PelvEx Collaborative
    Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
    Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
    Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: analysis of short- and long-term effects].
    Tang JQ; Zhang JZ; Mei SW; Hu G; Wan YL; Wang X; Wang XS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):253-259. PubMed ID: 36925125
    [No Abstract]   [Full Text] [Related]  

  • 17. Laparoscopic Pelvic Exenteration for Locally Advanced Rectal Cancer, Technique and Short-Term Outcomes.
    Pokharkar A; Kammar P; D'souza A; Bhamre R; Sugoor P; Saklani A
    J Laparoendosc Adv Surg Tech A; 2018 Dec; 28(12):1489-1494. PubMed ID: 29741977
    [No Abstract]   [Full Text] [Related]  

  • 18. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.